Loading clinical trials...
Loading clinical trials...
Post-marketing surveillance study to evaluate the real world safety and effectiveness of Viekira/ Exviera (paritaprevir/ritonavir/ombitasvir and dasabuvir) administered under a normal, routine treatme...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT07388979 · HIV - Human Immunodeficiency Virus, HBV (Hepatitis B Virus), and more
NCT04366973 · Hepatitis C Virus (HCV)
NCT04577482 · Hepatitis C Virus (HCV)
NCT02219490 · Chronic Hepatitis C Virus (HCV) Infection Genotype 1
NCT02167945 · Chronic Hepatitis C Virus (HCV) Infection Genotype 1
Dong-A University Hospital /ID# 167362
Busan, Busan Gwang Yeogsi
Pusan National University Hosp /ID# 167363
Busan, Busan Gwang Yeogsi
Kyungpook National Univ Hosp /ID# 168731
Daegu, Daegu Gwang Yeogsi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions